The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.
Clinical trial NCT05696392 · TERMINATED
Trial details
- NCT number
- NCT05696392
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2025-01-22
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.